eGFR: a calculated estimate of kidney filtration
Estimated glomerular filtration rate, or eGFR, is a calculated indicator of how much blood your kidneys filter each minute. It is not a substance in your blood but a number derived from a routine blood test. The calculation uses the level of creatinine (a waste product from muscle activity) and sometimes cystatin C (a small protein made by most cells), combined with your age and sex, to estimate the filtering work done by the kidney's tiny sieves (glomeruli).
eGFR captures the kidney's overall filtering capacity. It reflects how effectively the kidneys clear everyday wastes, balance water and salts, and help keep the body's internal chemistry steady (homeostasis). Because it summarizes complex kidney function into a single, trackable value, eGFR enables early recognition of reduced filtration, supports decisions about medication dosing and imaging choices, and helps monitor kidney health over time (glomerular function).
Why filtration capacity ripples beyond the kidneys
Estimated glomerular filtration rate (eGFR) is the most appropriate single snapshot of how well your kidneys are filtering the blood. It reflects how efficiently millions of tiny filters (glomeruli) clear waste, balance fluids and electrolytes, activate vitamin D, and help regulate blood pressure and red blood cell production—functions that ripple across the heart, bones, nerves, and brain.
eGFR estimates how much blood your kidneys filter each minute. It's a core gauge of whole‑body homeostasis: kidneys clear metabolic wastes, balance fluids, electrolytes, and acid–base, regulate blood pressure, and activate hormones for red blood cells and bone. Because of this, eGFR ties directly to energy, cognition, cardiovascular risk, and immune and metabolic stability.
Reading the filtration number across ranges
In most adults, a healthy value sits around 90 or higher. Values in the 60–89 range can be acceptable, especially with aging and if urine tests show no kidney damage. Persistently below 60 signals reduced kidney function, and below 30 indicates severe loss. For any age, "within reference ranges" tends toward the higher end for that person when paired with a normal urine albumin result.
When the number is lower, it means fewer working nephrons or reduced filtration pressure. Waste products accumulate, salt and water can be retained, and potassium or acid levels may shift. People may notice fatigue, ankle swelling, rising blood pressure, itchy skin, cramps, poor appetite, or mental fog—though early stages are often silent. Reduced kidney hormone activity can cause anemia and bone fragility. In children, growth and school performance can be affected. In pregnancy, a low value is concerning because filtration normally rises.
When the number is higher than expected, it can reflect hyperfiltration—seen in early diabetes, obesity, and normal pregnancy—which can precede later decline. It may also be an overestimate in people with very low muscle mass, since creatinine-based equations can read "high" despite true function being ordinary.
What can bias the eGFR estimate
eGFR is calculated from serum creatinine and/or cystatin C using equations that incorporate age and sex; newer formulas avoid race adjustment. Many labs call >90 normal, 60–89 mildly reduced, and persistent <60 indicative of chronic kidney disease. Results vary with assay, acute illness, hydration shifts, and drugs that affect creatinine handling. Apparent highs also occur when creatinine is low from low muscle mass, liver disease, or small body size.
Where eGFR fits in long-term kidney care
Big picture: eGFR links kidney health to cardiovascular risk, bone and blood health, medication handling, and long-term outcomes. Interpreting it alongside urine albumin, blood pressure, glucose, and electrolytes clarifies risk and trajectory over time. Low values usually reflect reduced filtration capacity of the kidneys, from chronic kidney disease or a sudden drop in function (acute kidney injury). Physiology shifts toward fluid and salt retention, rising blood pressure, buildup of uremic toxins that sap energy and clarity, and disturbances in potassium and acid–base balance. Reduced erythropoietin and vitamin D activation can drive anemia and bone–mineral changes. eGFR declines with age; however, values lower than expected for age, or any sustained drop, carry higher cardiovascular and systemic risk. In pregnancy, low eGFR is concerning because normal physiology increases filtration. High values usually reflect increased filtration (hyperfiltration) or an overestimate. Hyperfiltration occurs in early diabetes, high‑flow states, and normal pregnancy; if persistent, it can stress glomeruli and precede decline. Being in range suggests adequate nephron function with stable electrolyte control, acid–base balance, and efficient toxin clearance. Blood pressure regulation and kidney hormonal functions are likely intact, supporting cardiovascular and cognitive resilience. In adults, optimal tends to sit in the higher end of the age‑appropriate range, especially when urine albumin is absent.
FAQs
eGFR testing estimates how well your kidneys filter blood each minute using creatinine (and sometimes cystatin C) along with age and sex. It provides a clear snapshot of kidney function.
Testing eGFR helps detect silent kidney changes early, links kidney status with heart and metabolic risk, informs medication safety, and guides follow-up testing such as urine albumin.
Test periodically to establish a baseline and track trends. Frequency depends on your health status and risk factors such as diabetes, hypertension, or a history of kidney concerns.
Muscle mass, age, sex, hydration, recent intense exercise, high-protein meals, creatine use, certain medications (e.g., NSAIDs), and acute illness can influence eGFR. Using cystatin C can reduce the impact of muscle mass on the estimate.
Fasting is usually not required. Arrive well hydrated, avoid unusually intense exercise and very high-protein meals shortly beforehand, and try to test under similar conditions each time for consistent comparisons.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., Grams, M. E., Greene, T., Grubb, A., Gudnason, V., Gutierrez, O. M., Kalil, R., Karger, A. B., Mauer, M., Navis, G., ... Levey, A. S. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. The New England Journal of Medicine, 385(19), 1737-1749. https://doi.org/10.1056/NEJMoa2102953
- Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., 3rd, Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., & Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604-612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117-S314. https://doi.org/10.1016/j.kint.2023.10.018
- Gounden, V., Bhatt, H., & Jialal, I. (2024). Renal function tests. In StatPearls. StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29939598/
- Hosten, A. O. (1990). BUN and creatinine. In H. K. Walker, W. D. Hall, & J. W. Hurst (Eds.), Clinical methods: The history, physical, and laboratory examinations (3rd ed.). Butterworths. https://pubmed.ncbi.nlm.nih.gov/21250147/






































.avif)
